rs1057519964
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519965
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519966
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519966
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519967
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519967
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519968
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519968
|
SPOP;LOC107984999
|
Malignant Uterine Corpus Neoplasm
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519968
|
SPOP;LOC107984999
|
Malignant Uterine Corpus Neoplasm
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519968
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519969
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519969
|
SPOP;LOC107984999
|
Malignant Uterine Corpus Neoplasm
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519970
|
SPOP;LOC107984999
|
Malignant Uterine Corpus Neoplasm
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519970
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519971
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519971
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519972
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs193920894
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs193921065
|
SPOP;LOC107984999
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs193920894
|
SPOP;LOC107984999
|
Malignant neoplasm of prostate
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1057519966
|
SPOP;LOC107984999
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Applying these SRM assays to analyze HEK293T cells with and without expression of the three most frequent SPOP mutations in prostate cancer (Y87N, F102C or F133V) led to confident detection of all three SPOP mutations in corresponding positive cell lines but not in the negative cell lines.
|
28810879 |
2017 |
rs1057519966
|
SPOP;LOC107984999
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
Applying these SRM assays to analyze HEK293T cells with and without expression of the three most frequent SPOP mutations in prostate cancer (Y87N, F102C or F133V) led to confident detection of all three SPOP mutations in corresponding positive cell lines but not in the negative cell lines.
|
28810879 |
2017 |
rs1057519972
|
SPOP;LOC107984999
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Applying these SRM assays to analyze HEK293T cells with and without expression of the three most frequent SPOP mutations in prostate cancer (Y87N, F102C or F133V) led to confident detection of all three SPOP mutations in corresponding positive cell lines but not in the negative cell lines.
|
28810879 |
2017 |
rs1057519972
|
SPOP;LOC107984999
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
Applying these SRM assays to analyze HEK293T cells with and without expression of the three most frequent SPOP mutations in prostate cancer (Y87N, F102C or F133V) led to confident detection of all three SPOP mutations in corresponding positive cell lines but not in the negative cell lines.
|
28810879 |
2017 |
rs1057519971
|
SPOP;LOC107984999
|
Prostatic Neoplasms
|
|
0.010 |
GeneticVariation |
BEFREE |
We sequenced the SPOP gene to identify somatic mutations in 49 AA prostate tumors and identified three missense mutations (p.Y87C, p.F102S, and p.G111E) in five AA prostate tumors (10%) and one synonymous variant (p.I106I) in one tumor.
|
24994784 |
2015 |